Lewanski, Conrad R., Gullick, William J. (2001) Radiotherapy and Cellular Signalling. Lancet Oncology, 2 (6). pp. 366-370. ISSN 1470-2045. (doi:10.1016/S1470-2045(00)00391-0) (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:3952)
PDF (Radiotherapy)
Language: English Restricted to Repository staff only |
|
|
|
Official URL: http://dx.doi.org/10.1016/S1470-2045(00)00391-0 |
Abstract
Developments in cellular and molecular biology in the past decade have increased our understanding of the processes by which cells respond to ionising radiation. Cells use complex protein signalling systems that recognise radiation damage to DNA and plasma membrane lipids. When damage is found, it leads to the activation of various intracellular pathways that modulate the activity of genes controlling ceflular responses such as apoptosis, cell-cycle arrest, or repair. Numerous molecular targets may be activated or inhibited in an attempt to upregulatre or downregulate the radiation response. In this review, we discuss some of the new compounds and techniques for manipulating the cell's response to radiation.
Item Type: | Article |
---|---|
DOI/Identification number: | 10.1016/S1470-2045(00)00391-0 |
Additional information: | Review Article |
Subjects: |
Q Science R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology |
Divisions: | Divisions > Division of Natural Sciences > Biosciences |
Depositing User: | William Gullick |
Date Deposited: | 25 Sep 2009 14:29 UTC |
Last Modified: | 05 Nov 2024 09:35 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/3952 (The current URI for this page, for reference purposes) |
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):